Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
About this study
The mechanisms of sensitivity and resistance to oncogene-targeted therapy can be determined from tumor tissue or tumor cell lines derived from available archival samples and/or from standard-of-care re-biopsy upon suspected tumor progression.
- Condition
- Lung Neoplasms
- Sponsor
- University of Colorado, Denver
Who can join
- Age
- 18 to 85 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 7
- Minimum age: 18 years
- Maximum age: 85 years
- Study condition: Lung Neoplasms
- Patients undergoing investigation or treatment for thoracic cancers with oncogene-targeted therapies
- Aged 18 years or older
- Either a) have suspected tumor progression or other condition that dictates a standard-of-care palliative, therapeutic, or diagnostic intervention including but not limited to procedures such as bronchoscopic biopsy, computed tomography (CT) or ultra-sound (US)-guided biopsy, thoracentesis, video assisted thoracoscopic (VATS) pleurodesis, lobectomy, adrenalectomy or pleural catheter placement, providing tumor specimen appropriate molecular analysis or b) have previously had biopsy/surgical intervention with tumor tissue at University of Colorado or an outside institution available for medullar analysis.
- Patients must have the ability to understand and willingness to sign an informed consent document.
Where
1 site, 1 recruiting
University of Colorado Cancer Center
Aurora, Colorado, United States
Contact
-
Brandi Kubala
303-724-1657 brandi.kubala@cuanschutz.edu
Potential match only. Final eligibility is determined by the study team.